Searle & Co. Pfizer Inc Transaction History

Searle & Co.

$396 Million
Q3 2024

A detailed history of Searle & Co. transactions in Pfizer Inc stock. As of the latest transaction made, Searle & Co. holds 93,069 shares of PFE stock, worth $2.39 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

93,069

Previous 111,697 16.68%

Holding current value

$2.39 Million

Previous $3.13 Million 13.82%

% of portfolio

0.68%

Previous 0.74%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$27.7 - $31.39 $515,995 - $584,732	-18,628 Reduced 16.68%	93,069 $2.69 Million
Q2 2024 Jul 30, 2024	BUY	$25.26 - $29.6 $1.55 Million - $1.82 Million	61,354 Added 121.87%	111,697 $3.13 Million
Q1 2024 May 09, 2024	SELL	$25.89 - $29.73 $181,230 - $208,110	-7,000 Reduced 12.21%	50,343 $1.4 Million
Q4 2023 Feb 05, 2024	SELL	$26.13 - $33.94 $639,374 - $830,477	-24,469 Reduced 29.91%	57,343 $1.65 Million
Q3 2023 Nov 03, 2023	SELL	$32.09 - $37.51 $40,240 - $47,037	-1,254 Reduced 1.51%	81,812 $2.71 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $54,035 - $62,517	-1,496 Reduced 1.77%	83,066 $3.05 Million
Q1 2023 Jun 01, 2023	SELL	$39.39 - $51.28 $63,024 - $82,048	-1,600 Reduced 1.86%	84,562 $3.45 Million
Q1 2022 May 10, 2022	BUY	$45.75 - $56.69 $77,775 - $96,373	1,700 Added 2.01%	86,162 $4.46 Million
Q4 2021 Jan 19, 2022	BUY	$41.32 - $61.25 $150,776 - $223,501	3,649 Added 4.52%	84,462 $4.99 Million
Q3 2021 Oct 08, 2021	BUY	$39.25 - $50.42 $19,625 - $25,210	500 Added 0.62%	80,813 $3.48 Million
Q2 2021 Jul 29, 2021	SELL	$35.91 - $40.68 $323,189 - $366,120	-9,000 Reduced 10.08%	80,313 $3.15 Million
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $301,410 - $339,930	9,000 Added 11.21%	89,313 $3.24 Million
Q4 2020 Feb 04, 2021	SELL	$33.47 - $42.56 $20,082 - $25,536	-600 Reduced 0.74%	80,313 $2.96 Million
Q3 2020 Oct 30, 2020	SELL	$31.75 - $37.25 $182,562 - $214,187	-5,750 Reduced 6.63%	80,913 $2.97 Million
Q2 2020 Aug 03, 2020	SELL	$30.12 - $36.54 $3,493 - $4,238	-116 Reduced 0.13%	86,663 $2.83 Million
Q1 2020 May 12, 2020	BUY	$27.03 - $38.62 $216,240 - $308,960	8,000 Added 10.15%	86,779 $2.83 Million
Q4 2019 Jan 21, 2020	BUY	$32.92 - $37.36 $26,204 - $29,738	796 Added 1.02%	78,779 $3.09 Million
Q3 2019 Oct 22, 2019	SELL	$32.49 - $42.13 $25,862 - $33,535	-796 Reduced 1.01%	77,983 $2.8 Million
Q1 2019 Apr 22, 2019	BUY	$37.5 - $41.2 $26,475 - $29,087	706 Added 0.9%	78,779 $3.35 Million
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $7,694 - $8,772	-200 Reduced 0.26%	78,073 $3.41 Million
Q3 2018 Oct 16, 2018	SELL	$34.47 - $41.81 $3,447 - $4,181	-100 Reduced 0.13%	78,273 $3.45 Million
Q4 2017 Jan 17, 2018	BUY	$33.26 - $35.29 $8,315 - $8,822	250 Added 0.32%	78,373 $2.84 Million
Q3 2017 Oct 27, 2017	BUY	$31.0 - $34.15 $2.42 Million - $2.67 Million	78,123	78,123 $2.79 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Searle & Co., based on Form 13F filings with the SEC.

News

Stay updated on Searle & Co. with notifications on news.

Account